CB

Cancer Biology & Medicine

Cancer Biology & Medicine is dedicated to reporting the latest advances in cancer research around the world by presenting high quality articles, especially on translational cancer research, to bridge the gap between bench and bedside. The journal promotes academic exchange in cancer between China and the rest of the world and covers topics including cancer genetics, cancer and stem cell biology, molecular and clinical immunology, cancer prevention and epidemiology, cancer biomarkers, radiation oncology, oncology clinical trials, mechanisms of drug sensitivity and resistance, targeted therapy and immunotherapy, and multidisciplinary treatment and personalized medicine.

Looking to publish in Cancer Biology & Medicine? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Impact Factor 8.4
Quartile Q1
Open Access Type Open
ISSN 2095-3941
eISSN 2095-3941
Invitation Only No
Cost Range Article processing charges may be required after editorial acceptance; journal-specific APCs vary by journal.

Submission Instructions

Cancer Biology & Medicine accepts the following article types. Click on an article type to view submission instructions.

Original Article

Cover Letter A cover letter is required. Cover letter must include the manuscript title, a brief summary of the significant findings or points, a statement of exclusive submission and no plagiarism or other misconducts, a statement that all authors have read and approved the manuscript for submission, the corresponding author’s name, address, and telephone number, and suggestions for appropriate reviewers and reviewer exclusions.
Abstract An abstract is required. Abstract must be 300 words. Abstract is preferably structured. Preferred abstract headings are Objective, Methods, Results, and Conclusion.
Manuscript Manuscript must contain 6,000 words of text. Manuscript must include title page, abstract, introduction, materials and methods, results, discussion, acknowledgements, conflict of interest statement, references, figures, tables, and supplementary information, with Results and Discussion presented as separate sections. Manuscript must include at least 5 keywords, a running title of no more than 10 words, and a statement specifying the contribution of every author on the title page.
References References must number 50 or more. References must be numbered in the order of first mention and include only articles that are published or in press, excluding abstracts, personal communications, and retracted articles.
Figures & Tables A maximum of 8 figures and/or tables may be included. Figures, tables, and supplementary information must be uploaded as separate files, and tables should be typed on separate sheets. Figures and tables must be numbered consecutively in Arabic numerals according to the order of first mention in the text.
Reformat to Cancer Biology & Medicine using Livewrite Premium

Review

Cover Letter A cover letter must be uploaded with the submission. The cover letter must include the manuscript title, a brief summary of the significant findings or points, a statement of exclusive submission and no plagiarism or other misconducts, a statement that all authors have read and approved the submission, the corresponding author's name, address, and telephone number, and suggestions for appropriate reviewers and reviewer exclusions.
Abstract Review submissions must include an abstract. Review submissions must include a 250-word abstract. The abstract should be a single paragraph.
Manuscript Review submissions must contain 7,000 words of text. At least 5 keywords should be provided.
References Review submissions must include 75 references or more. References must be numbered in the order of first mention.
Figures & Tables Review submissions may include a maximum of 7 figures and/or tables. Figures, tables, and the manuscript text must be uploaded as separate files. Figures should be labeled in consecutive Arabic numerals in the order mentioned in the text, and tables should be numbered consecutively in Arabic numerals according to first mention.
Reformat to Cancer Biology & Medicine using Livewrite Premium

Minireview

Cover Letter A cover letter is required. Cover letter must include the manuscript title, a brief summary of the significant findings or points, a statement of exclusive submission and no plagiarism or other misconducts, a statement that all authors approved submission, the corresponding author's name, address, and telephone number, and suggestions for appropriate reviewers and reviewer exclusions.
Abstract An abstract is required. Abstract must be 200 words. Abstract structure is not specified.
Manuscript Manuscript must contain 4,000 words of text. At least 5 keywords must be provided.
References References must total 50 or more. References must be numbered in the order of first mention and include only articles that are published or in press.
Figures & Tables A maximum of 5 figures and/or tables may be included. Figures must be submitted as separate files. Tables should be typed on separate sheets.
Reformat to Cancer Biology & Medicine using Livewrite Premium

Letter To The Editor

Cover Letter A cover letter must be uploaded with the submission. The cover letter must include the manuscript title, a brief summary of the significant findings or points, a statement of exclusive submission and no plagiarism or other misconduct, a statement that all authors have read and approved the submission, the corresponding author's name, address, and telephone number, and suggestions for reviewer inclusions or exclusions.
Abstract Abstract requirements are not specified.
Manuscript Letter To The Editor submissions must contain 500 words of text. At least 5 keywords should be provided.
References Letter To The Editor submissions must include 5 references or more. References must be numbered in the order of first mention.
Figures & Tables Figures, tables, and the text must be uploaded as separate files.
Reformat to Cancer Biology & Medicine using Livewrite Premium

Practice Guideline

Cover Letter A cover letter is required with the submission. The cover letter must include the manuscript title, a brief summary of the significant findings or points, statements of exclusive submission and no plagiarism or other misconduct, confirmation that all authors have read and approved the submission, the corresponding author’s name, address, and telephone number, and suggestions for and exclusions of reviewers.
Abstract An abstract is required. The abstract should be a single paragraph of about 250 words. The abstract must be unstructured as a single paragraph.
Manuscript At least 5 keywords should be provided.
References References must be numbered in the order of first mention and should include only articles that are published or in press, excluding abstracts, personal communications, and retracted articles.
Figures & Tables Tables should be typed on separate sheets and figures must be submitted as separate files. Tables and figures must be numbered consecutively in Arabic numerals according to the order of first mention in the text.
Reformat to Cancer Biology & Medicine using Livewrite Premium

Recent Publications

Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer: a prospective, multicenter, non-interventional study (FLOURISH)

Lisha Shen, Dongqing Lv, Ke-Jing Tang, Jun Zhao, Dan Zhu, Yanqiu Zhao, Ke Wang, Yan Wang, Zhigang Cai, Ligang Xing, Ke Xie, Jiuwei Cui, Lin Mu, Chao Cao, Liren Ding, Peifeng Chen, Jun Liang, Yongmin Ding, Liqin Lu, Jiliang Zhang, Xinmin Yu, Li Chen, Jing Zheng, Jianya Zhou, Jianying Zhou

10.20892/j.issn.2095-3941.2025.0566
View Publication

Treatment implications of T cell DNA damage in anti-tumor immunity

Xiaofei Jiao, Yiyang Shen, Yixuan Tang, Jiahao Liu, Qinglei Gao

10.20892/j.issn.2095-3941.2026.0020
View Publication

Microbial reprogramming of immunogenic cell death: a new paradigm in tumor immunotherapy

Yilin Li, Huiyue Zhang, Yun Feng, Kun Fang, Yue Wang, Yuhang Zhou, Tao Sun, Junnan Xu

10.20892/j.issn.2095-3941.2025.0769
View Publication

HBx-mediated GPT2 suppression promotes liver cancer development by downregulating ADH1A

Hongjuan You, Xing Wang, Ruyu Liu, Yuxin Wang, Huanyang Zhang, Lihong Ma, Ensi Bao, Yujie Zhong, Xiangye Liu, Delong Kong, Xiucheng Pan, Xiaocui Li, Suping Qin, Kuiyang Zheng, Chen Li, Renxian Tang, Fanyun Kong

10.20892/j.issn.2095-3941.2025.0236
View Publication

CAMK2D isoform 15 facilitates gefitinib resistance <italic>via</italic> AKT phosphorylation in lung adenocarcinoma

Lingmei Li, Danyang Ren, Yutian Wang, Jiaojiao Zhang, Chenhui Yan, Tongyuan Qu, Ruimin He, Wenshuai Zhang, Wanghao Li, Ningrui Feng, Yalei Wang, Yuhong Guo, Lisha Qi, Lu Cao, Qianru Guo, Qiang Zhao, Zhaoxiang Ye, Wenfeng Cao

10.20892/j.issn.2095-3941.2025.0710
View Publication

Frequently asked questions

How long does it take to publish?

Revised manuscripts should be submitted within two months after authors receive reviewers' comments. The journal generally allows only one round of revision.

Reformat to Cancer Biology & Medicine using Livewrite Premium

Is a cover letter required?

A cover letter is required for each submission. It should include the manuscript title, a brief summary of significant findings, a statement of exclusive submission and no plagiarism or other misconduct, a statement that all authors approved the submission, the corresponding author's contact information, and suggested reviewer inclusions or exclusions.

Reformat to Cancer Biology & Medicine using Livewrite Premium

What are the publication costs?

Most journals are Gold Open Access. Article processing charges may be required only after a manuscript is editorially accepted and before publication; journal-specific APCs vary by journal.

Reformat to Cancer Biology & Medicine using Livewrite Premium

Research Topics

Cancer Immunotherapy and Biomarkers Cancer Genomics and Diagnostics Immunotherapy and Immune Responses Ferroptosis and cancer prognosis Lung Cancer Treatments and Mutations Cancer Cells and Metastasis Immune cells in cancer Cancer-related molecular mechanisms research CAR-T cell therapy research Cancer, Hypoxia, and Metabolism Immune Cell Function and Interaction RNA modifications and cancer Hepatocellular Carcinoma Treatment and Prognosis Breast Cancer Treatment Studies Pancreatic and Hepatic Oncology Research Cholangiocarcinoma and Gallbladder Cancer Studies Lung Cancer Research Studies MicroRNA in disease regulation Epigenetics and DNA Methylation Nanoplatforms for cancer theranostics Cancer Research and Treatments Glioma Diagnosis and Treatment Gastric Cancer Management and Outcomes Nanoparticle-Based Drug Delivery Circular RNAs in diseases